Revvity Inc. Total Assets

Latest as of March 2026: $12.00 Billion USD

Revvity Inc. total assets. Based on the latest financial reports, Revvity Inc. (RVTY) holds total assets worth $12.00 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Revvity Inc. for the company's overall valuation and market capitalisation.

Total Assets of Revvity Inc. (1985–2025)

Total assets of Revvity Inc. from 1985 to 2025. This chart illustrates how Revvity Inc.'s total assets have evolved over time, based on quarterly financial data. See today's stock price for Revvity Inc. for real-time trading data and today's change.

Revvity Inc. - Asset Composition Analysis

Revvity Inc. Total Assets Breakdown (December 2025)

Revvity Inc. total assets breakdown as of December 2025. Revvity Inc.'s total assets of $12.00 Billion consist of 18.4% current assets and 81.6% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 7.6%
Accounts Receivable $744.67 Million 6.1%
Inventory $379.50 Million 3.1%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $2.35 Billion 19.3%
Goodwill $6.61 Billion 54.4%

Asset Composition Trend (1985–2025)

This chart illustrates how Revvity Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Revvity Inc. to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Revvity Inc.'s current assets represent 18.4% of total assets in 2025, a decrease from 62.5% in 1985.
  • Cash Position: Cash and equivalents constituted 7.6% of total assets in 2025, up from 4.1% in 1985.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 73.0% of total assets, an increase from 6.0% in 1985.
  • Asset Diversification: The largest asset category is goodwill at 54.4% of total assets.

Revvity Inc. Competitors by Total Assets

Key competitors of Revvity Inc. based on total assets are shown below.

Company Country Total Assets
Voxel S.A.
WAR:VOX
Poland zł746.13 Million
Leveljump Healthcare Corp
V:JUMP
Canada CA$18.29 Million
Prodia Widyahusada Tbk PT
JK:PRDA
Indonesia Rp2.57 Trillion
Sonic Healthcare Ltd
AU:SHL
Australia AU$16.78 Billion
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million
Healius Ltd
AU:HLS
Australia AU$1.77 Billion
Monash Ivf Group Ltd
AU:MVF
Australia AU$512.35 Million

Revvity Inc. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.72 3.58 2.01
Quick Ratio 1.41 2.99 1.56
Cash Ratio 0.00 0.00 0.00
Working Capital $889.67 Million $1.67 Billion $1.14 Billion

Revvity Inc. - Advanced Valuation Insights

This section examines the relationship between Revvity Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.75
Latest Market Cap to Assets Ratio 1.00
Asset Growth Rate (YoY) -1.8%
Total Assets $12.17 Billion
Market Capitalization $12.20 Billion USD

Valuation Analysis

Near Book Valuation: The market values Revvity Inc.'s assets close to their book value (1.00x), suggesting investors view the company's assets at approximately fair value.

Slight Asset Contraction: Revvity Inc.'s assets decreased by 1.8% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Revvity Inc. (1985–2025)

The table below shows the annual total assets of Revvity Inc. from 1985 to 2025.

Year Total Assets Change
2025-12-31 $12.17 Billion -1.81%
2024-12-31 $12.39 Billion -8.64%
2023-12-31 $13.56 Billion -4.00%
2022-12-31 $14.13 Billion -5.80%
2021-12-31 $15.00 Billion +88.44%
2020-12-31 $7.96 Billion +21.74%
2019-12-31 $6.54 Billion +9.42%
2018-12-31 $5.98 Billion -1.90%
2017-12-31 $6.09 Billion +42.43%
2016-12-31 $4.28 Billion +2.65%
2015-12-31 $4.17 Billion +0.94%
2014-12-31 $4.13 Billion +4.58%
2013-12-31 $3.95 Billion +1.15%
2012-12-31 $3.90 Billion +1.20%
2011-12-31 $3.86 Billion +20.15%
2010-12-31 $3.21 Billion +4.90%
2009-12-31 $3.06 Billion +4.34%
2008-12-31 $2.93 Billion -0.60%
2007-12-31 $2.95 Billion +17.49%
2006-12-31 $2.51 Billion -6.80%
2005-12-31 $2.69 Billion +4.58%
2004-12-31 $2.58 Billion -1.24%
2003-12-31 $2.61 Billion -8.06%
2002-12-31 $2.84 Billion -4.50%
2001-12-31 $2.97 Billion +35.72%
2000-12-31 $2.19 Billion +27.63%
1999-12-31 $1.71 Billion +50.56%
1998-12-31 $1.14 Billion +36.86%
1997-12-31 $832.10 Million +1.12%
1996-12-31 $822.90 Million +2.36%
1995-12-31 $803.90 Million +1.36%
1994-12-31 $793.10 Million +3.16%
1993-12-31 $768.80 Million +2.55%
1992-12-31 $749.70 Million +7.42%
1991-12-31 $697.90 Million +3.36%
1990-12-31 $675.20 Million +4.94%
1989-12-31 $643.40 Million +19.30%
1988-12-31 $539.30 Million +4.62%
1987-12-31 $515.50 Million +15.79%
1986-12-31 $445.20 Million +3.58%
1985-12-31 $429.80 Million --

About Revvity Inc.

NYSE:RVTY USA Diagnostics & Research
Market Cap
$17.51 Billion
Market Cap Rank
#1844 Global
#705 in USA
Share Price
$157.00
Change (1 day)
-5.30%
52-Week Range
$82.26 - $165.78
All Time High
$199.71
About

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectio… Read more